Leading EU Pharma Company Pohl-Boskamp Launches Myrtol(R) 300 in the U.S.
Natural Remedy for Fighting Cough and Cold Symptoms Now Available to U.S. Consumers Without a Prescription
(firmenpresse) - LOS ANGELES, CA -- (Marketwired) -- 11/01/16 -- Myrtol® 300, a cough/cold and respiratory health supplement, is launching in the United States. The natural remedy will be available for the first time to U.S. consumers after 40 years of success in over 23 countries.
Composed of plant-derived essential oils, Myrtol® 300 is used to help fight related to lung and sinus congestion. The supplement helps loosen mucus and makes it easier to cough and expel irritants in the airways, while also helping and inflammation. It has been tested in over 27 clinical trials and is clinically proven to help clear and maintain a healthy respiratory tract.
"After seeing the long-term success and strong consumer following in various countries, we knew it was time to introduce Myrtol® 300 to the U.S. market," said Thomas Höppner, Executive Director, Marketing and Sales at Pohl-Boskamp. "We have had many users describe how powerful Myrtol® 300 is and how it helped eliminate their cold naturally and quickly from the inside out. We are thrilled to be able to provide this to families in the U.S."
Myrtol® 300 is clinically proven to help support:
Sinus and lung function
Healthy mucus production
Myrtol® 300 was invented by , a privately-owned family business with roots back to 1835, which has sold more than 250 million Myrtol capsules worldwide. The company was one of the first to introduce a capsule resistant to gastric juices and a capsule containing nitrate compounds, lending to their position as a leading pharmaceutical manufacturer in Europe. Operating by a philosophy focused on health for the whole body, Pohl-Boskamp creates products that provide consumers fast-acting and positive benefits.
Now available in the U.S., Myrtol® 300 can be purchased without a prescription. To learn more about Myrtol® 300, visit .
Myrtol® 300 is a natural remedy that helps fight cough and cold symptoms while supporting a healthy respiratory system. Recognized as the "German pill" with a funny name, Myrtol® 300 was initially launched in the European market and has been used for more than 40 years by millions of people in 23 different countries. The dietary supplement has been tested in 27 clinical trials and over 99 non-clinical trials proving to help users fight cough and cold symptoms and maintain overall sinus and lung health. Now available in the U.S., Myrtol® 300 can be purchased without a prescription.
Pohl-Boskamp is a privately-owned business active in the international pharmaceutical market for 175 years with commercialized products in more than 45 countries, and which has now emerged into the U.S. nutraceutical industry. Through close collaboration with its partners abroad, Pohl-Boskamp focuses on developing and marketing products that positively impact patients' quality of life. It operates in numerous healthcare sectors including pneumology, urology, parasitology, cardiovascular diseases and dermatology. Learn more at Pohl-Boskamp.com.
Image Available:
Brittany Galvan
(310) 405-0346
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 01.11.2016 - 13:36 Uhr
Sprache: Deutsch
News-ID 504106
Anzahl Zeichen: 0
contact information:
Town:
LOS ANGELES, CA
Kategorie:
Family
Diese Pressemitteilung wurde bisher 203 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Leading EU Pharma Company Pohl-Boskamp Launches Myrtol(R) 300 in the U.S."
steht unter der journalistisch-redaktionellen Verantwortung von
Pohl-Boskamp (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
